Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Phase 4
2(100.0%)
2Total
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05488236Completed

Nuclear Magnetic Resonance for Embryo Ploidy Selection

Role: lead

NCT07466199Phase 4Not Yet Recruiting

Exogenous Progesterone as Ovulation Trigger

Role: lead

NCT07461909Recruiting

Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer

Role: lead

NCT06307184Recruiting

Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer

Role: lead

NCT07087171Recruiting

AI-Driven Model Impact on Patient Engagement in Medically Assisted Reproduction

Role: lead

NCT03755973Phase 4Completed

Effect of Different Ovarian Stimulation Protocols on Endometrial Receptivity

Role: lead

NCT04849156Completed

Spermatozoa Morphology Selection by Thermotaxis

Role: lead

NCT04387994Completed

Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF.

Role: lead

NCT04546412Completed

Importance of the Microtubule Cytoskeleton in Oocyte Competence

Role: lead

All 9 trials loaded